Platelet‐poor plasma gel vs platelet‐rich plasma for infraorbital rejuvenation: A clinical and dermoscopic comparative study

Infraorbital dark circles and tear trough deformity are considered common aesthetic problems. Numerous therapeutic modalities have been suggested with variable outcomes. The aim of this study was to compare the efficacy of platelet‐poor plasma (PPP) gel vs platelet‐rich plasma (PRP) in infraorbital...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Dermatologic therapy 2020-11, Vol.33 (6), p.e14255-n/a
Hauptverfasser: Neinaa, Yomna Mazid El‐Hamd, Hodeib, Abeer Abd El‐Hakam, Morquos, Mariam Maher, Elgarhy, Lamia Hamouda
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Infraorbital dark circles and tear trough deformity are considered common aesthetic problems. Numerous therapeutic modalities have been suggested with variable outcomes. The aim of this study was to compare the efficacy of platelet‐poor plasma (PPP) gel vs platelet‐rich plasma (PRP) in infraorbital rejuvenation. A total of 68 females presented with dark circles and/or tear trough deformity were recruited and treated by PPP gel injection in the right infraorbital region (Group A) and PRP injection in the left infraorbital region (Group B). They received three treatment sessions at 2‐week interval, and followed up monthly for 3 months. They were evaluated clinically and dermoscopically before treatment and at the end of follow‐up period. Both groups showed significant clinical improvements proved by significant reduction of degree of hyperpigmentation and tear trough rating scale. Obviously, more significant clinical and dermoscopic improvements were observed in Group A than Group B. Therefore, it could be concluded that both PPP gel and PRP were clinically effective procedures for aesthetic improvement of infraorbital region. Moreover, PPP gel seems to be significantly more effective than PRP as a therapeutic modality.
ISSN:1396-0296
1529-8019
DOI:10.1111/dth.14255